The LXR nuclear receptors are intracellular sensors of cholesterol excess, and are activated by various oxysterols. LXRs have been shown to regulate multiple genes of lipid metabolism, including ABCA1 (formerly known as ABC1). ABCA1 is a lipid pump that effluxes cholesterol and phospholipid out of cells. ABCA1 deficiency causes extremely low HDL levels, demonstrating the importance of ABCA1 in the formation of HDL. The present work shows that acetylpodocarpic dimer (APD) is a potent, selective agonist for both LXRα (NR1H3) and LXRβ (NR1H2). In transient transactivation assays APD was approximately 1000-fold more potent, and yielded approximately 6-fold greater maximal stimulation, than the widely used LXR agonist 22-(R)-hydroxycholesterol. APD induced ABCA1 mRNA levels, and increased efflux of both cholesterol and phospholipid, from multiple cell types. Gas chromatography-mass spectrometry measurements demonstrated that APD stimulated efflux of endogenous cholesterol, eliminating any possible artifacts of cholesterol labeling. For both mRNA induction and stimulation of cholesterol efflux, APD was found to be more effective than was cholesterol-loading. Taken together, these data show that APD is a more effective LXR agonist than endogenous oxysterols. LXR agonists may, therefore, be useful for the prevention and treatment of atherosclerosis, especially in the context of low HDL levels.
Introduction
A key step in HDL metabolism has recently been uncovered through identification of the genetic defect responsible for Tangier Disease (1) (2) (3) (4) (5) . Patients with Tangier Disease have extremely low HDL, premature coronary heart disease, and accumulation of cholesterol in macrophages (6) . This condition derives from the inability to transfer cholesterol and phospholipid to apoA-I (7, 8) . The apoA-I that is not lipidated is then rapidly degraded and does not serve in reverse cholesterol transport. The defective gene was identified as ABCA1, a homologue of multidrug resistance proteins (1) (2) (3) (4) . In normal cells, ABCA1 is transcriptionally controlled and rises upon cholesterol loading (9) thus allowing macrophages (and other cells) to rid themselves of excess cholesterol.
ABCA1 appears to play a key role in controlling cholesterol efflux from tissues and HDL levels because of its sensitivity to intracellular cholesterol levels (9) , the ability of ABCA1 overexpression to enhance cholesterol efflux (10) , and emerging data associating low HDL levels in CHD patients to genetic variants of ABCA1 (11) . Thus, elevation of ABCA1 is predicted to drive the exit of cholesterol from cells such as macrophages in atherosclerotic lesions and to elevate plasma HDL levels.
ABCA1 expression increases in cells upon cholesterol-loading (9) , and this is dependent on the nuclear receptors LXRα (NR1H3) and/or LXRβ (NR1H2) (12) (13) (14) (15) . Cellular cholesterol-loading presumably leads to the production of endogenous oxysterol ligand(s) for LXR. Both LXR subtypes are activated by oxysterols (16) . Taken together, these data suggest that small molecule agonists of LXR might be therapeutically useful for enhancing the removal of cholesterol from peripheral tissues and increasing circulating HDL levels, leading to a reduction in atherosclerosis.
In the present work, we describe a potent, specific agonist of LXR that induces ABCA1 and increases cholesterol efflux to a greater extent than does cholesterol-loading.
Methods
Materials-Human LDL was isolated and acetylated as previously described (17) . Pure human apoA-I was obtain from Biodesign International, Saco, Maine, and desalted on PD-10 columns (Amersham Pharmacia) prior to its use in cholesterol efflux assays. Acetyl-podocarpic dimer (APD; Figure 1 ) was synthesized at the Merck Research Laboratories, Rahway, NJ.
Cells-All cells were cultured at 37C in a humidified atmosphere consisting of 95% air and 5% carbon dioxide. Primary human fibroblasts were obtained from the Camden human cell repository.
The cells were grown, handled, and cholesterol-loaded exactly as described by Francis et al. (8) .
Human primary hepatocytes were received from In Vitro Technologies (Baltimore, MD) in 6 well dishes and maintained in phenol red-free DMEM (high glucose) containing 10% charcoal-stripped FCS (Gemini Bio-Products, Inc., Calabasas, CA), 1% nonessential amino acids, 1% glutamine and 100 units/ml Penicillin G and 100 µg/ml Streptomycin sulfate. Caco-2 cells were obtained from ATCC and grown in Opti-MEM (GIBCO #51985-034) containing 10 % FCS, non-essential amino acids (Gibco #11140-050), and vitamins (Gibco # 11120-052). THP-1 cells were obtained from ATCC and were grown in RPMI medium (Sigma Cat.# R8005) containing 10% FCS, 0.05 µM 2-mercaptoethanol, 1mM sodium pyruvate, 2mM L-Glutamine, and Antibiotic-Antimyotic Solution (Sigma Cat.# A9909, 100U/ml Penicillin, 0.1 µg/ml Streptomycin, 0.25 µg/ml Amphotericin B).
THP-1 cells were differentiated into macrophages in 6-well tissue culture dishes at a density of 1 million cells/well by incubation in the same medium plus 100 nM tetradecanoyl phorbol acetate for three days. After differentiation into macrophages, cells were used for mRNA measurements or for cholesterol efflux assays as described below. Human primary monocytes were prepared as described (18) , and differentiated to macrophages by culturing for 7 days in Teflon jars in RPMI-1640 medium supplemented with 12% human serum, 100 units/ml penicillin and 100 µg/ml streptomycin sulfate) (19) . They were then plated in the same medium to initiate experiments.
Assays of cholesterol efflux using 3 H-cholesterol-Cells were labeled by incubation for 24 hours in fresh growth media containing 3 H-cholesterol (10 µCi/ml). In some experiments, cells were simultaneously labeled with 3 H-cholesterol and cholesterol-loaded using acetylated LDL (20) (concentrations and times are reported). Following labeling with 3 H-cholesterol, cells were washed and incubated an additional 24 hours in serum-free media containing 1 mg/ml BSA, to allow for equilibration of 3 H-cholesterol with intracellular cholesterol. Cholesterol efflux was initiated by adding the indicated amount of apoA-I, usually 10 µg/ml, with or without APD, in serum-free medium. APD was added to cell culture medium from DMSO solutions, and control cells received an equivalent amount of DMSO, never exceeding 0.1%. After 24 hours, media were harvested and cells dissolved in 1 mM HEPES, pH 7.5 containing 0.5% Triton X-100. Media were briefly centrifuged to remove non-adherent cells, and then aliquots of both the supernatants and the dissolved cells were subjected to liquid scintillation spectrometry to determine radioactivity.
Cholesterol efflux is expressed as a percentage, calculated as ( 3 H-cholesterol in medium/( 3 Hcholesterol in medium + 3 H-cholesterol in cells)) x 100.
Assays of cholesterol efflux using gas chromatography-mass spectrometry-Cells were handled as described above, except that 3 H-cholesterol was omitted. At the end of the 24 hour efflux assay, Calabasas, CA), 1% nonessential amino acids, 1% glutamine and 100 units/ml Penicillin G and 100 µg/ml Streptomycin sulfate. Cell lysates were prepared from washed cells using cell lysis buffer (Promega Corp., Madison WI) according to the manufacturer's directions. Luciferase activity in cell extracts was determined using Luciferase Assay Buffer (Promega) in a ML3000 luminometer (Dynatech Laboratories). GFP expression was determined using the Tecan Spectrofluor Plus at excitation wavelength of 485nm and emission at 535nm. Luciferase activity was normalized to GFP expression to account for any variation in efficiency of transfection. 
Measurement of mRNA levels by real-time quantitative RT-PCR (TaqMan

Results
APD is a potent and selective ligand for LXRα and LXRβ-APD was identified as an LXR agonist
during random screening of the Merck chemical collection. The structure of APD is shown in Figure 1 . APD was tested in transactivation assays of both LXRα and LXRβ, and compared to 22-(R)-hydroxycholesterol, which is an LXR agonist that has been widely used in cell culture assays (16) . As shown in Figure 2 , APD was ~1000-fold more potent than 22-(R)-hydroxycholesterol.
Furthermore, the maximal stimulation achieved with APD was at least 6-fold higher than for 22-(R)-hydroxycholesterol. APD was found to be inactive in similar transactivation assays for the nuclear receptors PPARI, PPARK, PPARL, and RXR (data not shown).
APD activates LXRα and LXRβ in a cell-free assay-To determine whether APD interacts directly
with LXRα and LXRβ, we used a cell-free assay of receptor activation that we have previously described (22, 23) . This assay uses homogeneous time-resolved fluorescence to measure liganddependent interaction of LXR with steroid receptor co-activator-1 (SRC-1). As shown in Figure   3 , the presence of APD causes LXR to interact with SRC-1. APD is much more potent than 22-(R)-hydroxycholesterol in this assay, and also yields a greater extent of activation, consistent with the results from the transactivation assay shown in Figure 2 . APD was found to be inactive in similar assays of co-activator association for the nuclear receptors FXR, ERI and ERβ (data not shown).
APD induced ABCA1 mRNA-It has recently been reported that LXR controls the expression of the ABCA1 gene (12) (13) (14) (15) . We incubated cultured THP-1 cells with APD and measured ABCA1 mRNA levels by real-time quantitative RT-PCR. The data in Figure 4 show that APD was ~1000 times more potent than 22-(R)-hydroxycholesterol.
Induction of ABCA1 mRNA by APD was not limited to THP-1 cells. Table 1 shows the induction of ABCA1 mRNA by APD in human primary hepatocytes and Caco-2 cells. The data in Table 1 also show that APD induced the ABCG1 gene (formerly ABC8 or human white), which was recently reported to be regulated by LXR (24) .
APD was more effective than cholesterol-loading for increasing ABCA1 mRNA levels-Cholesterol-loading has been reported to increase ABCA1 mRNA levels in macrophages. It is likely that cholesterol-loading increases ABCA1 mRNA levels by promoting the formation of endogenous LXR ligands, presumably oxysterols. To determine the relative potency of endogenous ligands vs APD for the stimulation of ABCA1 mRNA levels, we incubated primary human monocyte-macrophages with acetylated LDL and/or APD. Following these treatments, we measured cellular content of cholesterol and mRNA levels for ABCA1 and ABCG1. As shown in Table 2 , acetylated LDL approximately doubled cellular cholesterol content, and increased mRNA levels for ABCA1 by 2-fold and ABCG1 by 5-fold. APD increased mRNA levels for both ABCA1 and ABCG1 dramatically, and to a greater extent than did cholesterol-loading.
Furthermore, the addition of APD together with acetylated LDL led to greater mRNA induction than acetylated LDL alone. These data show the APD is a more potent LXR agonist than the agonist(s) endogenously produced upon cholesterol loading.
APD increased cholesterol efflux from cultured cells-ABCA1 is believed to function as a lipid pump, transferring cellular cholesterol to apoA-I. To determine if APD increased cholesterol efflux, THP-1 cells were labeled with 3 H-cholesterol and then incubated with various concentrations of APD in the presence or absence of 10 µg/ml apoA-I. The data in Figure 5 show that APD increased cholesterol efflux, consistent with the mRNA data in Figure 4 . Two lines of evidence support the conclusion that APD stimulates cholesterol efflux by induction of ABCA1 expression through LXR, and eliminate the possibility that APD increased 3 H-cholesterol in the medium by causing non-specific cell lysis or deterioration. First, the stimulation of 3 H-cholesterol efflux was dependent upon the presence of apoA-I, which is known to be required for the action of ABCA1. Secondly, in the experiment shown in Figure 5 , parallel wells were labeled with 3 Hleucine rather than 3 H-cholesterol, but otherwise handled exactly the same. APD had no effect on the apparent "efflux" of 3 H-protein into the medium (data not shown), indicating that APD did not cause cellular lysis.
The ability of APD to increase cholesterol efflux was not limited to THP-1 cells. Figure 6 shows that APD increased cholesterol efflux from human primary monocyte-macrophages and Caco-2 cells. In multiple cell types and in multiple experiments, the apparent EC 50 for stimulation of cholesterol efflux was approximately 1 nM APD. This potency matches well with the potency of APD in transactivation assays using LXR-Gal4 fusion constructs.
APD stimulated cholesterol efflux from cholesterol-loaded primary human fibroblasts-The data
shown above indicate that APD increased cholesterol efflux onto apoA-I from cells with a normal cholesterol status. Cholesterol-loading of fibroblasts increases cholesterol efflux onto apoA-I, and this activity is absent in fibroblasts from patients with Tangier disease that lack ABCA1 (7, 8) Table 3 show that APD increased efflux of cholesterol, phosphatidylcholine, and sphingomyelin. We obtained similar results using human primary monocyte-macrophages. These data indicate that APD stimulates typical ABCA1 action, leading to efflux of both phospholipid and cholesterol (8, 10, 25) .
APD was more effective than cholesterol-loading for stimulation of cellular cholesterol efflux-The
data shown above demonstrate that APD increased efflux of 3 H-cholesterol from multiple cell types. Although many investigators have used 3 H-cholesterol-labeling to measure cellular cholesterol efflux, it has been shown that cellular cholesterol pools do not always label uniformly (26) (27) (28) . To demonstrate that APD authentically increases efflux of endogenous cholesterol, we quantitated cholesterol efflux from human primary monocyte-macrophages by measuring the mass of cholesterol in the cells and the medium. Human primary monocyte-macrophages were incubated with 1 µM APD, or DMSO, for 24 hours in the presence of 10 µg/ml apoA-I. Some of the cells had previously been cholesterol-loaded using acetylated LDL. The data in Figure 8 show that APD stimulated efflux of endogenous cholesterol from the macrophages, whether or not the cells had been cholesterol-loaded. APD increased cholesterol mass in the medium, which can be viewed as the product of the enzymatic reaction catalyzed by ABCA1. The percent of cellular cholesterol effluxed also increased with APD. It is particularly noteworthy that APD was capable of stimulating cholesterol efflux from cholesterol-loaded cells. This shows that APD is more effective than cholesterol-loading at increasing cellular cholesterol efflux. This is consistent with the mRNA data shown in Table 2 .
Comparison of APD to exogenous oxysterols on macrophages-
The data above indicate that APD is more effective at stimulating LXR-driven responses than is cholesterol-loading. We have recently shown that 27-hydroxycholesterol, the enzymatic product of the enzyme encoded by the cyp27 gene, is an endogenous LXR ligand in cholesterol-loaded human cells (23) . We directly compared APD to exogenous 27-hydroxycholesterol, and other oxysterols, for the ability to increase mRNA levels of LXR target genes and stimulate cholesterol efflux. As shown in Figure 9 , APD was significantly more effective than exogenous 27-hydroxycholesterol for induction of ABCA1 and stimulation of cholesterol efflux. The widely used LXR agonist 22-(R)-hydroxycholesterol was more effective than 27-hydroxycholesterol, but less effective than APD. It is known that 27-hydroxycholesterol is efficiently secreted from cells (29) , but there is no information on secretion of 22-(R)-hydroxycholesterol. If the latter oxysterol is not efficiently secreted, then it may accumulate intracellularly and therefore be more effective than 27-hydroxycholesterol.
The most striking difference between APD and the exogenous oxysterols was the much greater induction of expression of the LXR target genes ABCG1 and SREBP-1c by APD ( Figure   9 ). This dramatic difference may have been caused by one of the pleiotropic effects of oxysterols, specifically their ability to block the maturation of SREBP proteins (reviewed by Schroepfer in (30)). LXR activation by APD would be expected to stimulate transcription of the SREBP-1c gene (31) (32) (33) , leading to increased levels of active, mature SREBP-1c which can feed-forward and stimulate more transcription of the gene (34) . Oxysterols, on the other hand, can block maturation of SREBP-1c thus preventing this feed-forward amplification.
Discussion
Cholesterol-loaded macrophage foam cells are a hallmark of atherosclerotic lesions (35). Although advanced human atherosclerotic lesions contain other cell types, it has been suggested that the lipid-rich portion of the lesion is most prone to rupture and cause myocardial infarction (36) .
Therefore, novel therapeutic agents that increase lipid removal from lesions might improve the outcome for patients with coronary artery disease.
Cells that are cholesterol-loaded in cell culture can unload excess cholesterol onto HDL or free apoA-I. Fibroblasts from patients with Tangier disease are unable to unload cholesterol normally (7, 8) . The gene defective in Tangier disease was recently identified as ABCA1, a member of the ATP-binding cassette superfamily of genes (1) (2) (3) (4) . This superfamily includes many genes known to be pumps, and it is believed that ABCA1 is a cholesterol and/or phospholipid pump. Mutations in ABCA1 decrease HDL levels and increase the risk of coronary artery disease (6, 11) . Taken together, these data strongly suggest that ABCA1 participates in the removal of excess cholesterol from atherosclerotic lesions.
Expression of the ABCA1 gene is increased by cholesterol-loading of cultured cells (9) . This control is believed to be mediated by LXR nuclear receptors (12) (13) (14) (15) . LXRI and LXRβ are two very similar nuclear receptors, both of which are activated by various oxysterols (16) . LXRα has been shown to be necessary for the normal response of mice to cholesterol-feeding (37) . It is likely that cholesterol-loading causes production of regulatory oxysterols that activate LXR and thereby turn on genes necessary for removal of excess cholesterol. We have recently shown that 27-hydroxycholesterol is the major oxysterol that activates LXR in cholesterol-loaded human cells (23) . Other members of the ABC superfamily of genes have also been reported to be controlled by cholesterol loading (38) or by LXR (24) .
In the present work we have shown that APD is a potent and specific activator of LXR. APD was effective at 1-10 nM in four different assays of LXR function: transactivation assays using LXRGal4 fusion constructs, ligand-dependent recruitment of co-activator in a cell-free assay, induction of endogenous ABCA1 mRNA, and stimulation of cholesterol efflux. Our data are fully consistent with the previous reports that LXR regulates ABCA1 gene expression (12) (13) (14) (15) . The present work adds to this field of research in the 4 following ways: 1. Previous reports that LXR ligands stimulate cholesterol efflux have used oxysterols as the LXR agonists (14, 15) . This requires µM levels of oxysterol, which might cause changes in the physical properties of the plasma membrane of the cells (39) , especially because these concentrations probably exceed their authentic water solubility. Furthermore, 7-keto-cholesterol has been reported to decrease cholesterol efflux (40) .
High concentrations of oxysterols may act pleiotropically, and therefore some of the effects of oxysterols on cholesterol efflux may not be related to LXR function (39) . In contrast, we show that APD induces ABCA1 mRNA levels and increases cholesterol efflux at 1-10 nM, comparable to the concentrations required for activation of LXR in transient transfection assays. 2. The potent and selective LXR agonist T0901317 has been shown to induce expression of ABCA1 and other LXRresponsive genes (13, 31, 32) , however, an increase in cellular cholesterol efflux in response to T0901317 was not demonstrated. Our data indicate that the potent and selective LXR agonist APD increases cholesterol efflux from multiple cell types. 3 . Most published assays of cholesterol efflux rely on labeling with exogenous 3 H-cholesterol to trace endogenous cellular cholesterol. It has, however, been shown that exogenous 3 H-cholesterol does not uniformly label all cellular cholesterol pools (26) (27) (28) . We therefore used GC-MS to prove that APD increases efflux of endogenous cellular cholesterol. 4. Finally, we show that APD can stimulate ABCA1 gene expression and cholesterol efflux to a greater extent than does cholesterol-loading. This novel observation is important because the target cells for LXR activation in human disease are the cholesterol-loaded cells in atherosclerotic lesions. If cholesterol-loading caused a maximal increase in ABCA1 expression, then exogenous synthetic agonists might not be able to alter the course of disease. Our data indicate the opposite, in that synthetic LXR agonists may represent novel therapeutic agents for coronary artery disease. Table 1 . APD induced mRNA for ABCA1 and ABCG1 in human primary hepatocytes and Caco-2 cells.
Human primary hepatocytes and Caco-2 cells were cultured as described in Methods, and incubated with 100 nM APD. After twenty-four hours, cells were harvested, total RNA was prepared and specific mRNA levels were measured as described in Methods. The results are expressed as fold induction vs DMSO control. Values given are mean and SEM for triplicate wells of Caco-2 cells, and of three independent experiments using three different preparations of human primary hepatocytes.
Fold induction of mRNA levels by 100 nM APD Cell type ABCA1 ABCG1
Human Primary Hepatocytes 5.1 ± 0.82 11.4 ± 6.1
Caco-2 cells 4.9 ± 0.54 16.2 ± 0.64 Table 2 . APD increased ABCA1 mRNA levels to a greater extent than did cholesterol-loading.
Human primary peripheral blood monocyte-macrophages were plated at a density of 1 million cells/well in 12-well plates, allowed to adhere overnight, then washed and incubated with or without 100 µg/ml of acetylated LDL for 48 hours. Some of the cells were given 1 µM APD for the last 24 hours. Cells were then harvested, and one set of triplicate wells was used to measure cellular cholesterol content. Another set of triplicate wells was used to measure mRNA levels. Data are expressed as mean and SEM. P values were calculated using unpaired, two-tailed t-tests. Similar Table 3 . APD stimulated the efflux of cholesterol and phospholipids to similar extents.
THP-1 cells were plated at 200,000 cells per well in 48-wells, differentiated into macrophages, and then incubated with 100 µg/ml acetylated LDL, 10 µCi/ml 3 H-cholesterol, and 10 µCi/ml 3 Hcholine chloride for 4 days. After the labeling medium was removed, the cells were incubated with 
